Pfizer/BioNTech initiate application with EU regulator for updated COVID vaccine
Earlier in June, Europe's medicine regulators backed the World Health Organization's recommendation to update the antigen composition of COVID shots to target one of the currently dominant XBB variants ahead of the upcoming autumn vaccination campaign. Pfizer/BioNTech said they expect to be ready to ship XBB.1.5-adapted monovalent vaccines to member states of the European Union immediately following regulatory approval.
Krishna Chandra Eluri Raghav Mahobe European Union European Medicines Agency Drug Administration World Health Organization
Source: yahoo.com